lobbying_activities: 162056

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
162056	5c153f50-ba1d-45d3-9713-c230b967bf44	MM	ZUCKERMAN SPAEDER LLP	42160	BARR LABORATORIES	2002	mid_year	MED	Intersection between Hatch-Waxman generic exclusivity and pediatric exclusivity.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2002-08-13T00:00:00-04:00